Literature DB >> 21548465

Cancer epigenetics and targeted therapies.

Benjamin Tycko1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21548465

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  6 in total

1.  RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer.

Authors:  Hui Liu; Zhantao Yan; Qianqian Yin; Kai Cao; Yu Wei; Jaime Rodriguez-Canales; Dongshen Ma; Yongping Wu
Journal:  J Histochem Cytochem       Date:  2018-08-22       Impact factor: 2.479

2.  Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer.

Authors:  Xiaobin Wang; Huihan Wang; Renge Bu; Xiang Fei; Chenghai Zhao; Yongsheng Song
Journal:  Oncol Lett       Date:  2012-05-11       Impact factor: 2.967

3.  CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.

Authors:  Qi-Ming Yu; Xin-Bao Wang; Jun Luo; Shi Wang; Xian-Hua Fang; Jiang-Liu Yu; Zhi-Qiang Ling
Journal:  J Surg Oncol       Date:  2012-04-18       Impact factor: 3.454

4.  mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.

Authors:  Brandon R Beagle; Duc M Nguyen; Sharmila Mallya; Sarah S Tang; Mengrou Lu; Zhihong Zeng; Marina Konopleva; Thanh-Trang Vo; David A Fruman
Journal:  Oncotarget       Date:  2015-02-10

5.  ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.

Authors:  Gao-Yan Tang; Guo-Jun Tang; Lu Yin; Chen Chao; Ren Zhou; Guo-Ping Ren; Jia-Yu Chen; Wei Zhang
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

6.  RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line.

Authors:  Hua-Feng Kang; Zhi-Jun Dai; He-Ping Bai; Wang-Feng Lu; Xiao-Bin Ma; Xing Bao; Shuai Lin; Xi-Jing Wang
Journal:  Onco Targets Ther       Date:  2013-04-17       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.